Welcome to BioBOUNCE

A stock market analyzer of volatile BioTech stocks.

BioBounce has a proven track record for correctly predicting the time to purchase a selected biotech stock.

Register for a new account now and get a 14 day free trial.

Member Login

Forgot password or username?

Not a member yet? Sign Up!

Welcome to BioBOUNCE

A stock market analyzer of volatile BioTech stocks.

BioBounce has a proven track record for correctly predicting the time to purchase a selected biotech stock.

Register for a new account now and get a 21 day free trial.

Member Login

Forgot password or username?

Not a member yet? Sign Up!

BioBOUNCE
"The safest place to look for a new trade is at the end of the first correction to a new swing"...W.D.Gann
(all Profits are based on a $5000.00 per trade)
BioBounce is a Biotech trading system that combines technical analysis and catalyst driven events.

The system is designed to hold up to 10 full Biotech positions and 5 ETF hedge positions. Because it is impossible to predict which trade will be profitable, the system is best utilized by taking the same position size for each ticker that triggers. Over time the system will build a portfolio.

Once the portfolio is filled with 10 tickers and two of the current holdings hit their target to sell 1/2 the position, one more ticker gets added to the Watchlist.

Here is how it works:

Biotech Trades ETF Trades
A Biotech trade capitalizes on the momentum of a stock while the ticker is in a bullish trend.
    One ...
    Buy at the entry price.
    Two ...
    Sell half of your position at the indicated target.
    Three ...
    As the stock moves higher, the ABANDON price will also move higher. Simply exit your position when the stock closes below the abandon price. This marks a reversal in trend, and the trade should be closed.
The ETF trades are a way to hedge your account in market down turns. They also provide exposure to other sectors and can offer diversification.
    One ...
    Buy at the entry price.
    Two ...
    Sell half of your position at the indicated target.
    Three ...
    As the stock moves higher, the ABANDON price will also move higher. Simply exit your position when the stock closes below the abandon price. This marks a reversal in trend, and the trade should be closed.


Because we provide our entry prices and profit taking targets BEFORE they happen, it is impossible for us to front run our members. Providing the information BEFORE it happens also gives you more time to prepare for the trade. This is especially important for our members that have difficulty trading during the day. Simply set your orders ahead of time and go about your day.

The free trial is No Risk, No Obligation, and No Credit Card Required.
Once your trial ends, you can use the link inside our members area to begin your subscription:
  • $49.99/month.
  • You can cancel at anytime, no questions asked.
  • REGISTER NOW!




Follow along with a chart of our history above and these current pullback trades.
Currently Held Positions
Symbol Type Last Orig Price Orig Date Return
ASNDBIOTECH19.1721.0108-26-2015-8.76%
DYAXBIOTECH23.6923.3908-27-20151.28%
MDCOBIOTECH33.6432.5008-28-20153.51%
THLDBIOTECH4.344.2608-28-20151.88%
What Do We Do?
It's simple, if a ticker is on any of our lists, it's perfectly fine to take an entry if and when it hits. Be sure to follow the rules and take profits as indicated or exit if you get an ABANDON alert at the end of day.

Taking small gains over time adds up, especially in a volatile sector such as Biotechnology.
Who Are We?
@BioBounce has over 15 years of commercial Biopharmaceutical experience. His knowledge of the biotech industry provides insight to the research side of our selection process.

@AlgoSniffer has been analyzing the stock market for 20+ years. He has developed a unique swing trading method that provides the insight into the technical analysis side of our selection process.

This website combines the expertise of @AlgoSniffer and @BioBounce.

Why Should You Be Interested?
"My first time buying today. Very happy, net covered cost of subscription on day when my IBD50 stocks tanked!"
@bpmswatch
"I really like how easy your system is to follow. VERY easy! You sure call em' to the penny...look at ALKS...big volume coming in right to the penny. Really Cool!"
Gary A.
"Hi Gonzo, Just want to thank you for NSPR. Got a small position in the ZONE and now watching it run. We appreciate your hard work with the spreadsheet and everything else."
BLY
"The spreadsheet is a thing of beauty! Your service is a must have for every trader and investor; priceless technical analysis! Thanks for all you do!"
Paul M.
"@AlgoSniffer OMG you're great!!! DDXS hit the target"
Andrilu C.
"The best way to stay unemotionally involved is don't know anything about the investment other than the symbol... That's being provided along with the price parameters... Then just play by the rules... There can be no emotional involvement... unless you like one set of letter better than another..."
Andrew J
"@AlgoSniffer You are rocking! Even when the bios are doing terribly."
Richard U
"Your spreadsheet is fantastic. Thanks for getting me perfectly positioned in KERX. My last 25% is now running, and that's exactly how this is supposed to work. Fantastic. I was floundering around, trying to do my own setups, stops and targets by the seat of the pants, but now I have found THE LIGHT. At $40 a month your service is set too cheap."
Scott K
"Don't get distracted and stick with the BioBounce/Gonzo watch list. Indeed, the only way to really make money on BIOs is to stick to the BioBounce/Gonzo method. Anything short of that is pure gamble and BIOs are never to be trusted, simply traded! And this is why BioBounce/Gonzo are successful! My 2 cents."
Thecatman
AlgoSniffer, LLC is the Publisher of BioBounce.com and @BioBounceAlerts. AlgoSniffer, LLC is not a Registered Investment Advisor.

BioBounce.com and @BioBounceAlerts are for informational purposes only and AlgoSniffer, LLC accepts no responsibility for any monetary losses incurred from use of the information provided.

Biotechnology is a highly volatile sector, and presents higher than average risk. As a subscriber of our service, you are responsible for your own due diligence regarding any and all tickers we provide on our watchlist.

General Information on the Regulation of Investment Advisers
Division of Investment Management
Exclusions From the Definition
Publishers of bona fide newspapers, news magazines, and business or financial publications of general and regular circulation. Under a decision of the United States Supreme Court, to enable a publisher to qualify for this exclusion, a publication must satisfy three elements: (1) the publication must offer only impersonal advice, i.e., advice not tailored to the individual needs of a specific client, group of clients, or portfolio; (2) the publication must be "bona fide," containing disinterested commentary and analysis rather than promotional material disseminated by someone touting particular securities, advertised lists of stocks "sure to go up," or information distributed as an incident to personalized investment services; and (3) the publication must be of general and regular circulation rather than issued from time to time in response to episodic market activity or events affecting the securities industry. See Lowe v. Securities and Exchange Commission, 472 U.S. 181 (1985).

source: http://www.sec.gov/divisions/investment/iaregulation/memoia.htm